The Food and Drug Administration (FDA) Bad Ad Program and Prescription Drug Promotion

The Food and Drug Administration (FDA) Bad Ad Program and Prescription Drug Promotion is organized by U S Food and Drug Administration (FDA).

Released Date: 07/13/2020
Expire Date: 07/13/2023

Description:
This activity will educate a national audience of healthcare professionals about the FDA Bad Ad program. It will also educate the nation's healthcare professionals about prescription drug advertising and promotion.

Learning Objectives:
Upon completion of this activity, participants will be able to:
• Identify the role that FDA’s Office of Prescription Drug Promotion, or OPDP, plays in regulating prescription drug promotion and advertising.
• Recognize persuasive techniques commonly used in advertising and promotion.
• Describe the most common regulatory issues raised by prescription drug promotion.
• Recognize potentially false or misleading prescription drug promotion.
• Locate the Bad Ad contact information.
• Translate knowledge into action and report potentially problematic prescription drug promotion to OPDP.